Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

NCT04447820 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: K-877-ER (Dose A)
DRUG: K-877-ER (Dose B)
DRUG: K-877-IR

Sponsor

Kowa Research Institute, Inc.